Bispecific Antibodies in the Management of Lymphoma — ASH 2025 Review
Jan 21, 2026
01:01:12
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
Prof Michael Dickinson from Peter MacCallum Cancer Centre in Melbourne, Australia, and Dr Laurie H Sehn from the University of British Columbia in Vancouver, Canada, discuss clinical cases and recent findings from the 2025 ASH Annual Meeting relating to the use of bispecific antibodies in the management of lymphoma.